Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03973372 · ClinicalTrials.gov registry record

ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement

A clinical trial of Cirrhosis, Liver and Transjugular Intrahepatic Portosystemic Shunt (TIPS), sponsored by University of Texas Southwestern Medical Center.

Active
Registry status
852
Enrollment target
14
Study locations

NCT03973372 is a study of Cirrhosis, Liver and Transjugular Intrahepatic Portosystemic Shunt (TIPS) that is active but no longer recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 852 participants, above the 217-participant average among 34 other Cirrhosis, Liver trials with a reported enrollment target (293% higher). The trial reports 14 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03973372, a study of Cirrhosis, Liver and Transjugular Intrahepatic Portosystemic Shunt (TIPS), is active but no longer recruiting, sponsored by University of Texas Southwestern Medical Center.

ACTIVE NOT RECRUITING
Registry status
852 participants
Enrollment target
14
Study locations

Study Summary

ALTA is a multicenter consortium focused on the management of portal hypertension. ALTA TIPS is a longitudinal observational study of patients who are undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement. ALTA will create a database that will provide clinical parameters and outcomes of patients undergoing TIPS as part of their standard of care in hopes of answering key clinical questions.

Conditions Studied

Cirrhosis, Liver Transjugular Intrahepatic Portosystemic Shunt (TIPS)

Study Locations (14)

California

  • Stanford - Redwood City
  • Scripps Health - San Diego
  • University of California San Francisco - San Francisco

Illinois

  • Northwestern - Chicago
  • University of Chicago - Chicago

Minnesota

  • University of Minnesota - Minneapolis
  • Mayo Clinic Rochester - Rochester

New York

  • Columbia University - New York
  • Weill Cornell - New York

Texas

  • Baylor Scott & White Liver Consultants of Texas - Dallas
  • University of Texas Southwestern Medical Center - Dallas

Arizona

  • University of Arizona - Phoenix

Florida

  • University of Florida - Gainesville

Wisconsin

  • University of Wisconsin Madison - Madison

Trial Details

FieldValue
Enrollment Target 852 participants
Start Date 2019-06-10
Est. Completion 2027-12

Sponsor

University of Texas Southwestern Medical Center

837 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03973372

The ClinicalTrials.gov registry entry for NCT03973372 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 852 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 217-participant average among 34 other Cirrhosis, Liver trials with a reported enrollment target (293% higher). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cirrhosis, Liver appearing as the primary indexed condition, and to 0 interventions.

NCT03973372 reports 14 study locations spanning 8 distinct geographic areas - top geographies include California, Illinois, Minnesota.

Frequently Asked Questions

What is clinical trial NCT03973372 about?

NCT03973372 is a clinical study titled "ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement". ALTA is a multicenter consortium focused on the management of portal hypertension. ALTA TIPS is a longitudinal observational study of patients who are undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement. ALTA will create a database that will provide clinical parameters and outc...

What is the current status of trial NCT03973372?

This trial is currently active not recruiting. The enrollment target is 852 participants. The study started on 2019-06-10. Estimated completion is 2027-12.

What conditions does trial NCT03973372 study?

This clinical trial studies the following conditions: Cirrhosis, Liver, Transjugular Intrahepatic Portosystemic Shunt (TIPS).

Who is sponsoring clinical trial NCT03973372?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03973372 being conducted?

This trial has 14 study locations across Arizona, California, Florida, Illinois, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cirrhosis, Liver

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cirrhosis, Liver

All registered trials for this condition

Transjugular Intrahepatic Portosystemic Shunt (TIPS)

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.